Delivery Order SPE2DR25D2005-SPE2DR26FF1K4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector packs (two-count units) with a ceiling value of $1,923.88. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by January 23, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $5,625.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of epinephrine 0.3 mg auto-injector kits (2-packs). This competitive award, which carries an ultimate completion date of January 13, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,264.83 and an ultimate completion date of January 15, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026),...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,729.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $10,789.57 and a firm fixed-price structure. This is a non-set-aside award, indicating the contract was competitively awarded to the vendor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $2,704.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for epinephrine 0.15 mg auto-injector (2-pack) with a ceiling value of $2,118.38 under a firm fixed-price contract. This delivery order is a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award utilized competitive procedures with no...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector auto-injector packs (2-count) on November 11, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1K4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,716.00 and an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $999,999,999.00 prime vendor agreement through December 2026 that serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Department of Defense and related healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a broad spectrum of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for auto-injectors supports the military healthcare supply chain with emergency medical supplies essential for field and clinical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/21/26 |